Discontinued — last reported Q3 '23
Humana AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss increased by 2.9% to $876.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 19.0%, from $1.08B to $876.00M. Over 3 years (FY 2022 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss shows a downward trend with a -15.9% CAGR.
afs_debt_securities_unrealized_loss_12m_plus_acc| Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.43B | $1.38B | $1.50B | $1.30B | $1.37B | $1.42B | $989.00M | $1.23B | $1.08B | $1.01B | $900.00M | $851.00M | $876.00M |
| QoQ Change | — | -3.5% | +8.6% | -13.3% | +5.2% | +3.8% | -30.3% | +24.5% | -12.2% | -6.2% | -11.2% | -5.4% | +2.9% |
| YoY Change | — | — | — | -9.2% | -1.0% | -5.4% | — | -5.3% | -20.9% | -28.5% | -9.0% | -30.9% | -19.0% |